neuromyelitis


Also found in: Dictionary, Medical.
Related to neuromyelitis: neuromyelitis optica

neuromyelitis

[¦nu̇r·ō‚mī·ə′līd·əs]
(medicine)
Inflammation of the spinal cord and of nerves.
Mentioned in ?
References in periodicals archive ?
About The Guthy-Jackson Charitable Foundation The Guthy-Jackson Charitable Foundation is dedicated to funding research that will lead to the prevention, treatment and eventual cure for neuromyelitis optica (NMO) spectrum disease, also known as Devic's Disease, a rare neurological disorder often misdiagnosed as multiple sclerosis (MS).
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
25) In this study, disease-specific deposits of IgG or activated complement that correlated with the known distribution of either foreign antigen or autoantigen, were detected in virus-infected cells in progressive multifocal leucoencephalopathy, subacute sclerosing panencephalitis and cytomegalovirus encephalitis; in glial limiting membranes in neuromyelitis optica; and in senile plaques in Alzheimer's dementia.
About Neuromyelitis Optica Because NMO has only recently been identified as a syndrome distinct from MS, it is difficult to know how many people have it.
Clinical and pathological features of neuromyelitis optica are consistent with a pathogenic role of antibodies against AQP-4
1) AQP-4 was identified as a target antigen in neuromyelitis optica (NMO) in 2005 (2) leading to the recognition of a group of diseases that may have a similar autoimmune process based on the presence of this antibody.
Groundbreaking Conference for Rare Neurological Disease - Neuromyelitis Optica (NMO) - Brings Together World's Top Doctors, Medical Researchers and Patients in Pursuit of a Cure
Alexion) announced that the Company's first-in-class terminal complement inhibitor, Soliris (eculizumab) has received a positive opinion for orphan medicinal product designation from the Committee for Orphan Medical Products (COMP) of the European Medicines Agency (EMA) for the treatment of neuromyelitis optica (NMO), a life-threatening, ultra-rare neurological disorder.
For example, neuromyelitis optica and recurrent transverse myelitis might be mistaken for MS as they can present with similar clinical features.
Founder of Guthy-Jackson Charitable Foundation Leading Quest to Find Cure for Daughter, Thousands of Americans Suffering from Disease Unknown by Most in Medical Establishment; Bringing Together World's Top Doctors, Medical Researchers to Share Medical Findings at 2009 Neuromyelitis Optica (NMO) Roundtable Conference, Nov.
Alexion) announced that Soliris (eculizumab), the Company's first-in-class terminal complement inhibitor, has been granted an orphan drug designation by the US Food and Drug Administration (FDA) for the treatment of neuromyelitis optica(NMO) - a life-threatening, ultra-rare neurological disorder.

Full browser ?